President and Founder

Dr. Veterinary Medicine, virologist, global networking in human and animal health, vaccines and diagnostics, global disease control, one health, public affairs with EU, WHO, Asian and African authorities and experienced in vaccine translational development.
Achievements in brief:

  • Discovery of H1N1 influenza in swine and its zoonotic role
  • Heading business units vaccines for swine and ruminants
  • Technical support and international regulatory affairs at Rhône-Mérieux, Merial
  • Creating sustainable collaboration between GAVI/The Vaccine Fund and the EU
  • Support to tuberculosis vaccine development at TBVI
  • Strengthening GALVMED vaccine networks in Africa, leading roles in EU networks ZAPI (platform technologies for human and animal vaccines, pandemic preparedness)
  • VAC2VAC (3R’s in vitro batch control), MANCO (development of monoclonal antibodies against SARSCoV-2)
  • Participation in DRIVE (flu vaccine effectiveness) and INNO4VAC (human infection models)
  • Overview of animal challenge models for COVID-19 vaccines, correlates of protection for COVID-19 vaccines
  • Participating in strategies on pandemic preparedness, high pathogenic influenza and African Swine Fever control
  • President of IABS (international Alliance for Biological Standardization) 2016-2022
  • Advisor to vaccine companies and disease control initiatives.

Other speakers

Emmanuel Hanon CEO Vicebio
Sven Arnouts Business Development Manager Ghent University - Provaxs
Lourdes Mottier Head of Business Development Strategy Elanco Animal Health
Hans Nauwynck - Panelist Professor University of Ghent
Michael Hemprich - Moderator
Stefaan Wera Chief Operating Officer/Co-founder Virovet
Lauren Carde - Moderator V.P. Operations and Regulatory Affairs Paul Dick and Associates
Klaus Hellmann - Moderator Chief Veterinary Officer Argenta
Vladimir Pucovsky Scientific Administrator EMA Europa
Jose Carlos Mancera - panelist Senior Clinical Manager Zoetis
Liesbeth Ceelen - Moderator CEO BioLizard
Stein Aerts - panelist Scientific Director & Group Leader VIB
Daniel Jameson - panelist CEO Biorelate
Johannes Charlier Managing Director Kreavet
Jan Wauters Science & Technology Counselor Flanders Investment & Trade
Roxane Feller Secretary General Animal Health Europe
Hans Van Der Weken Postdoctoral Researcher Ghent University
Niels Vander Elst Postdoctoral Researcher Ghent University & KULeuven
Jeroen De Buck Professor Veterinary Microbiology University of Calgary
Kathleen Marchal Professor Bioinformatics University of Ghent
Paul Hodgson Director of Operations VIDO
Nathalie Vanderheijden Coordinator fot the EUP AH&W University of Ghent
Ann Martens Dean of the Faculty of Veterinary Medicine Ghent University
Lionel Malbec Product Manager Quantoom Biosciences
Lucas Decuypere CEO Allegro
Jelena Suran CEO Apiotix Technologies
Paul Dick Founder and President Paul Dick and Associates
Laetitia Cicchelero Cross-Health platform coordinator - Provaxs University of Ghent
Hervé Poulet Director of Strategic Partnering Boehringer-Ingelheim Animal Health
Eduardo Pontes Associate Director Research Alliances (EU) - External Innovation Zoetis
Filip Goossens Senior Investment Manager PMV
Sanjay Vashee Professor and Rockville Campus Director J. Craig Venter Institute
Lucy Davidson Professor of Veterinary Clinical Genetics and MRC Clinician Scientist Fellow Royal Veterinary College
Charles Owen CEO 272BIO
Annelies Bogaerts CDO Benno Therapeutics
Andrea Mariani CEO Soundsafe Care
Thomas Demeester Assistant Professor University of Ghent
Matthias Hofer Managing Partner SC Group (Stonehaven Cozmix Group AG)
Mathieu Peyrou Global Pharmaceuticals Development Director CEVA
Steve Nanchen Head external innovation Elanco

Interested? Register now!

Register here